IMUNON to Participate in Upcoming Investor Conferences
Globe Newswire•08/10/2026•09:00 ET
0
Key Highlights
- ➤IMUNON CEO Stacy Lindborg will participate in two October 2026 investor conferences
- ➤Maxim Growth Summit oncology panel scheduled for October 14 at 9:00 a.m. ET
- ➤ThinkEquity Conference presentation scheduled for October 15 at 1:30 p.m. ET
- ➤IMUNON will host one-on-one meetings throughout both conferences
- ➤Phase 3 OVATION 3 study is evaluating lead program IMNN-001 in advanced ovarian cancer
Expert Statements
Stacy Lindborg, President and Chief Executive Officer of IMUNON
“will participate in the following October 2026 investor conferences”
LAWRENCEVILLE, N.J., Oct. 08, 2026 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage biotechnology company developing DNA-mediated immunotherapies, today announced that Stacy Lindborg, Ph.D., President and Chief Executive Officer, will participate in the following October 2026 investor conferences.
Maxim Growth Summit 2026 Date: October 12 - 14, 2026 Location: Hard Rock Hotel, New York, NY Presentation: Oncology Panel, October 14, 2026, at 9:00 a.m. ET
Get started
Create a free account to read the full story.